This Government Contract opportunity from Department Of Health And Human Services was posted on May 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source – Illumina
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health (NIH) intends to award a firm fixed price, sole source contract to Illumina, Inc. for a maintenance agreement covering the Illumina NextSeq 1000 Sequencing System at the Department of Transfusion Medicine (DTM) within the NIH Clinical Center. This procurement is justified on the basis that the equipment is manufactured and serviced exclusively by Illumina, making it in the government's best interest to acquire the required maintenance directly from the original manufacturer. The acquisition falls under the NAICS code 339112 for Surgical and Medical Instrument Manufacturing and complies with simplified acquisition procedures under FAR Part 13, permitting single-source procurement for purchases below the simplified acquisition threshold without competitive bidding. This notice serves as an announcement of the intent to sole source and is not a solicitation, meaning no quotations or proposals will be requested. Interested parties may express their interest and capabilities in response to this notice by May 10, 2026, however, the government reserves the right to proceed without competition based on its discretionary determination. The point of contact for this acquisition is Gregory Noland of the NIH Clinical Center Office of Purchasing and Contracts, who can be reached via email or phone. The place of performance is Bethesda, Maryland, and the contract will ensure continued support and maintenance of the NextSeq 1000 system, critical for the NIH's transfusion medicine operations.
General Info
Agency
NAICS
Place of Performance
MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
This acquisition is for a maintenance agreement for the Illumina NextSeq 1000 Sequencing System at the Department ofTransfusion Medicine (DTM) at the National Institutes ofHealth (NIH) Clinical Center (CC).
• Product Service Code: 6515 – Medical Instruments,Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-005075
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award afixed price purchase order to Illumina, Inc., located at 5200 Illumina Way, San Diego, CA 92122, on a firm fixed price sole source award basis to provide the Illumina NextSeq 1000 Sequencing System at the National Institutes of Health, Department of Transfusion Medicine (DTM).
The instrument is manufactured and serviced by the vendor. The equipment is required by the original manufacturer (Illumina, Inc.) and it is therefore deemed to be in the Government’s best interest that this item is procured from the manufactuer.
This acquisition is being conducted using policies unique tothe Federal Acquisition Regulation (FAR) Part 13 – SimplifiedAcquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold(SAT), contracting officers may solicit from one source if thecontracting officer determines that the circumstance of thecontract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified AcquisitionProcedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabili-ties in response to this posting. The determination by the Government not to compete the proposed requirementbased upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this postingnumber, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing datespecified in this announcement, to the attention of Gregory Noland, Contract Specialist via email to gregory.noland@nih.gov by May 10, 2026 at 1600 EST.